Thursday, 12 September 2013

Analysis: Indian pharma draws more FDA scrutiny as U.S. imports rise

By Tony Munroe and Sumeet Chatterjee MUMBAI (Reuters) - U.S. inspectors visiting a factory in India owned by drugmaker Wockhardt Ltd in March found torn data records in a waste heap and urinals that emptied into an open drain in a bathroom six met...

Source: http://health.yahoo.net/news/s/nm/analysis-indian-pharma-draws-more-fda-scrutiny-as-u-s-imports-rise

view website home homepage view homepage

No comments:

Post a Comment

Note: only a member of this blog may post a comment.